Larner College of Medicine

Kalev Freeman

Professor, Emergency Medicine and Pharmacology

Emergency Physician

Kalev Freeman
Alma mater(s)
  • Residency Emergency Medicine, Boston University, 2004-2007
  • Internship, Surgery, University of Colorado, 2003-2004
  • M.D., Medical Scientist Training Program, University of Colorado, 2003
  • Ph.D., Molecular Biology, University of Colorado, 2000
  • B.S., Celluar & Molecular Biology, University of Michigan, 1995

Areas of expertise

Emergency medicine, trauma, inflammation, hemostasis/thrombosis, vascular biology, endothelial cells, pharmacology/drug discovery, animal models, video microscopy.

BIO

Kalev Freeman is a physician-scientist whose research aims to improve outcomes after brain injuries and surgical trauma. Dr. Freeman leads an active research program focused on one of the most urgent challenges in acute critical care: the acute endotheliopathy that underlies multiorgan failure in trauma and shock. With continuous NIH funding since 2013, more than 60 peer-reviewed publications and over 2,100 citations, his research has had a major impact on the fields of trauma resuscitation and vascular biology. Seminal work from his laboratory has revealed fundamental mechanisms that produce endothelial cell injury and drive thrombo-inflammation and microvascular dysfunction in severe trauma. His team has been internationally recognized in the field for providing pivotal early-stage evidence that led to the development of modern diagnostic tools and resuscitation protocols for trauma-induced coagulopathy. His teaching draws from this research activity, including courses on drug discovery in Pharmacology.

Publications

Google Scholar

Awards and Achievements

  • Safety Partner Award, 2015
  • Junior Research Award, 2012
  • James E. Demeules Surgical Research Award, 2010 and 2011

Bio

Kalev Freeman is a physician-scientist whose research aims to improve outcomes after brain injuries and surgical trauma. Dr. Freeman leads an active research program focused on one of the most urgent challenges in acute critical care: the acute endotheliopathy that underlies multiorgan failure in trauma and shock. With continuous NIH funding since 2013, more than 60 peer-reviewed publications and over 2,100 citations, his research has had a major impact on the fields of trauma resuscitation and vascular biology. Seminal work from his laboratory has revealed fundamental mechanisms that produce endothelial cell injury and drive thrombo-inflammation and microvascular dysfunction in severe trauma. His team has been internationally recognized in the field for providing pivotal early-stage evidence that led to the development of modern diagnostic tools and resuscitation protocols for trauma-induced coagulopathy. His teaching draws from this research activity, including courses on drug discovery in Pharmacology.

Publications

Awards and Achievements

  • Safety Partner Award, 2015
  • Junior Research Award, 2012
  • James E. Demeules Surgical Research Award, 2010 and 2011

Professional Societies and Memberships

American Board of Emergency Medicine (ABEM)

Fellow of the American College of Emergency Physicians (FACEP)